How to Read and Analyze a White Paper?

What Are Crypto Debit Cards?

What Is Web 3.0?

What Is Yield Farming?

What Is Crypto Lending?

What Is the Metaverse?

What Are Fan Tokens?

Newbie Catchup: The A-Z of NFTs

What Are Automated Market Makers?

What Is a Crypto ETF?

Check Today's SLP Price Here

**What is Triall (TRL)?**
Triall is an end-to-end digital ecosystem of blockchain-enabled software solutions for clinical trials. 

The project leverages blockchain, Artificial Intelligence, and related technologies to make clinical trial processes tamper-resistant, and to enable secure and compliant connections between the many isolated systems and parties involved in clinical research.

Triall’s native TRL token enables access to ecosystem utilities, P2P compensation, governance, and community engagement. 

The project is on a mission to accelerate the introduction of safe and affordable new vaccines and therapeutics into society by streamlining clinical trial operations.


**Who are the founders of TRL?**
Triall was founded by a group of clinical operations experts, enterprise IT specialists, and blockchain developers. 

Combined, their team has managed 100+ clinical trials, co-founded 20+ business ventures, and published 250+ peer-reviewed papers on innovation in medical research.  This experience has left Triall with an extensive network within clinical research and the Life Sciences at large.

Triall has built an international network of partners and a global advisory board consisting of industry experts and Key Opinion Leaders that support the project in the buildout of its blockchain-enabled ecosystem.


**What makes Triall unique?**
As frontrunner in the clinical trials industry, Triall applies blockchain technology to address two industry-wide needs: (1) promoting traceability and auditability of clinical trial operations, which have become increasingly complex and data-heavy; and (2) enabling secure and compliant transfer of clinical trial data between organizations and systems, thereby promoting interoperability and tackling the growing problem of data fragmentation.

Triall takes an ‘ecosystem approach’ that is unique to the clinical trials industry: by enabling secure and compliant integrations between currently isolated clinical trial software, the project aims to turn current competitors into cooperators for the benefit of faster and more-efficient clinical trials. To this end, the project leverages emerging open blockchain standards such as Decentralized Identifiers (DIDs) and Verifiable Credentials (VCs). These will shape a decentralized identity and access management infrastructure for connecting systems and their users in a secure environment.

TriallTRL

Triall Links

Links

Explorers

Community

Triall Contracts

Triall Tags

Industry

Self-Reported Tags

Triall Price (TRL)